Biocept Inc logo

BIOC - Biocept Inc News Story

$4.6 -0.3  -5.2%

Last Trade - 09/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £45.0m
Enterprise Value £36.3m
Revenue £20.0m
Position in Universe 5515th / 6827

BRIEF-Biocept And Protean BioDiagnostics Establish Research Collaboration To Demonstrate Advantages Of Biocept’s Target Selector Assay Kit For Non-Small Cell Lung Cancer Patients

Tue 23rd February, 2021 1:18pm
Feb 23 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT AND PROTEAN BIODIAGNOSTICS ESTABLISH RESEARCH
COLLABORATION TO DEMONSTRATE ADVANTAGES OF BIOCEPT’S TARGET
SELECTOR™ ASSAY KIT FOR NON-SMALL CELL LUNG CANCER PATIENTS

Source text for Eikon:  ID:nBw7qWZfBa 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.